Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease

OBJECTIVES: Levodopa-carbidopa intestinal gel (LCIG) was developed to reduce motor complications in Parkinson’s disease (PD) caused by pulsatile levodopa plasma concentrations following oral levodopa administration. Dyskinesia and ‘wearing off’ symptoms can vary between Asian and Caucasian patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Neurol Disord
Main Authors: Murata, Miho, Mihara, Masahito, Hasegawa, Kazuko, Jeon, Beomseok, Tsai, Chon-Haw, Nishikawa, Noriko, Oeda, Tomoko, Yokoyama, Masayuki, Robieson, Weining Z., Chatamra, Krai, Facheris, Maurizio F., Benesh, Janet
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833238/
https://ncbi.nlm.nih.gov/pubmed/29511383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418759315
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados